Built for the demands of oncology trials.
Build faster, adapt mid-study, and maintain real-time control with agentic eCOA and an agent platform designed for the complexity of oncology trials, from first patient in to close-out.
Oncology experience
Oncology studies delivered
Indications across the program
Countries worldwide
Evidence generation that works in the real world
Have confidence in your endpoints with high adherence, validated data capture, and consistent execution. Gain the speed, control, and traceability needed to support patients at every step.
Scale your oncology program with confidence
- Experiences co-designed with patients, caregivers, and sites fit naturally into daily life.
- AI-assisted builds and shared oncology eCOA catalogue streamline study startup; mid-study updates happen through configuration, not code.
- Caregiver ObsRO, proxy entry, and three-way Televisit keep data flowing when patients need caregiver's support most.
- The agent platform surfaces signals and flags compliance risks across cycles and cohorts, always with human-in-the-loop controls.
Build once, deploy across the program
Design once, then store and reuse across your oncology program. Standardized, validated eCOA and translation assets— with built-in best practices, notification logic, and data standards— combine with your own instruments for consistent, repeatable builds. No-code configuration and AI-assisted authoring mean mid-study updates happen easily.
.webp)
Designed for oncology science
Consistent execution across assets with support for validated instruments and custom ePRO diaries for sponsor-driven algorithm development. Automated site and patient notifications fire on threshold responses, and episodic diaries for bleeding, pain, and GI symptoms power real-time, proactive toxicity management.
One platform for every user.
eCOA, eConsent, Televisit, caregiver workflows, and site tools, all unified with single sign-on. Multimedia eConsent with remote amendment deployment, caregiver ObsRO and ePRO proxy entry, multiple consent types and signers, plus BYOD and provisioned devices to meet diverse patient needs globally.
A new agentic operating model for oncology
Oncology trials outpace what teams can manage alone. Agents are the force multiplier that make them operable at scale with human-in-the-loop oversight at every step.
Oncology studies demand more than an eCOA vendor
Built to support modern oncology trials with scalable workflows, caregiver capabilities, reusable assessments, and expert study design guidance.
- Global eConsent and re-consent
- Site, patient, and caregiver televisit
- Oncology assessment library
- Configurable notifications
- Long-term follow-up (LTFU)
- Caregiver and ObsRO workflows
- Protocol consulting by oncology and eCOA trial experts
- 24/7 site and patient support
The Medable difference in oncology
adherence driven by experiences that fit naturally into patients' and sites' daily lives
build and deploy timelines, with AI-assisted builds and oncology eCOA libraries
of patients potentially receiving more timely intervention that ultimately improves their outcomes
.jpg)
Case Study
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly expand the number of oncology trials it could concurrently conduct.
Better evidence. Better experience. Faster path to patients.
- Trials start faster and stay on track, with fewer dropouts and lower site burden
- Cleaner, inspection-ready data across every endpoint and visit
- Real-time safety and quality signals that enable earlier clinical decisions
- Reliable, actionable insights that reflect the real patient experience